Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Rectal CancerErectile Dysfunction
Interventions
PROCEDURE

Laparoscopic surgery

Completely resected rectal tumor.

DEVICE

NeuroRegen scaffold transplantation

After completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold to the nerve.

BIOLOGICAL

NeuroRegen scaffold/BMMCs transplantation

Completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold loaded with 5 million bone marrow mononuclear cells to the nerve.

BIOLOGICAL

NeuroRegen scaffold/HUC-MSCs transplantation

Completely resected rectal tumor, exposed pelvic autonomic nerves, and then transplanted NeuroRegen scaffold loaded with 5 million human umbilical cord mesenchymal cells to the nerve.

Trial Locations (1)

210008

RECRUITING

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing

Sponsors
All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

lead

Chinese Academy of Sciences

OTHER_GOV

NCT02648386 - Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery | Biotech Hunter | Biotech Hunter